Press Release for the Audited Consolidated and Standalone Financial Results for the quarter and financial year ended March 31, 2026
TATACHEM · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 1.7 pts less than Nifty Smallcap 250 and 1.3 pts less than its Commodity Chemicals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Tata Chemicals reported Q4FY26 consolidated revenue of ₹3,438 Cr (down 2% YoY) and EBITDA of ₹274 Cr (vs ₹327 Cr in Q4FY25), impacted by subdued soda ash pricing globally. The company took an exceptional impairment charge of ₹1,837 Cr for goodwill in US operations and ₹159 Cr deferred tax asset write-off amid challenging export market conditions. Consolidated PAT (before exceptional items and NCI) turned negative at ₹(279) Cr vs ₹(12) Cr in Q4FY25. Net debt stood at ₹5,961 Cr. Standalone performance was more resilient with 9% revenue growth to ₹4,831 Cr and 17% EBITDA growth to ₹954 Cr, supported by higher India volumes and cost controls. The board recommended a dividend of ₹11 per share. The company completed the Novabay Pte. Limited acquisition in March 2026 and approved a ₹100 Cr investment to debottleneck salt capacity at Mithapur. Non-soda ash revenue grew 14% YoY.
The large goodwill impairment in US and persistent pricing pressure across geographies signal near-term headwinds for consolidated profitability, though the resilient standalone performance and dividend provide some support. The strong debt position needs monitoring.